Larson Financial Group LLC Moderna, Inc. Transaction History

Larson Financial Group LLC

$1.45 Billion
Q2 2024

A detailed history of Larson Financial Group LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 593 shares of MRNA stock, worth $38,989. This represents 0.0% of its overall portfolio holdings.

Number of Shares

593

Previous 32 1753.13%

Holding current value

$38,989

Previous $3,000 2233.33%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$101.21 - $166.61 $56,778 - $93,468	561 Added 1753.13%	593 $70,000
Q4 2023 Feb 01, 2024	SELL	$69.51 - $104.43 $5,769 - $8,667	-83 Reduced 72.17%	32 $3,000
Q3 2023 Nov 03, 2023	SELL	$96.41 - $126.61 $771 - $1,012	-8 Reduced 6.5%	115 $11,000
Q2 2023 Aug 03, 2023	BUY	$118.5 - $160.53 $474 - $642	4 Added 3.36%	123 $14,000
Q2 2022 Aug 04, 2022	BUY	$117.13 - $176.59 $937 - $1,412	8 Added 7.21%	119 $17,000
Q1 2022 May 05, 2022	SELL	$126.46 - $235.05 $8,852 - $16,453	-70 Reduced 38.67%	111 $19,000
Q4 2021 Feb 03, 2022	BUY	$225.82 - $368.51 $9,032 - $14,740	40 Added 28.37%	181 $46,000
Q3 2021 Nov 04, 2021	BUY	$221.9 - $484.47 $8,876 - $19,378	40 Added 39.6%	141 $54,000
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $4,676 - $8,459	-36 Reduced 26.28%	101 $24,000
Q1 2021 May 06, 2021	BUY	$109.18 - $185.98 $1,200 - $2,045	11 Added 8.73%	137 $18,000
Q4 2020 Jan 14, 2021	SELL	$65.74 - $169.86 $74,154 - $191,602	-1,128 Reduced 89.95%	126 $13,000
Q3 2020 Oct 08, 2020	SELL	$54.34 - $94.85 $16,193 - $28,265	-298 Reduced 19.2%	1,254 $89,000
Q2 2020 Jul 10, 2020	BUY	$29.67 - $80.0 $45,543 - $122,800	1,535 Added 9029.41%	1,552 $100,000
Q1 2020 Apr 09, 2020	BUY	$17.78 - $31.58 $302 - $536	17 New	17 $1,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.

Account

Larson Financial Group LLC Moderna, Inc. Transaction History